National Oesophago-Gastric Cancer Audit, 2015

Making clinical audit data transparent. In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer. The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative. From April 2012, the audit has been extended to include patients with Oesophageal High-Grade Dysplasia (HGD). The National Oesophago-gastric Cancer Audit is a high profile, collaborative, national clinical audit for oesophago-gastric cancer run jointly by The Health and Social Care Information Centre, The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG) and The Clinical Effectiveness Unit at the Royal College of Surgeons of England. The audit aims to improve the quality of care and survival of patients with Oesophago-gastric cancer. It meets the requirements as set out in the NHS Cancer Plan and NICE guidelines. Accessing the data The data are being made available on the data.gov website. Each year files of data from the National Oesophago-Gastric Cancer Audit will be made available in CSV format. Trusts and Networks are identified by name and organisation code. What does the data cover? The data measures levels of completeness for data submitted to the National Oesophago-Gastric Cancer Audit and measures of performance and participation in the audit at trust level for key performance measures. Further details of these can be found in the annexes of the National Oesophago-Gastric Cancer Audit Report 2015. - Audit participation by NHS Trust and data completeness for the key fields. - Measures about the process of care given to patients. - Information about care outcomes and treatment. These data do not list individual patient information, nor do they contain any patient identifiable data. Are all Trusts included? All Trusts in England and Wales that manage patients diagnosed with oesophago-gastric cancer are included. What period does the data cover? The National Oesophago-gastric Cancer Audit 2015 covers the time period from 1st April 2012 to 31st March 2014 and includes hospital sites within England and Wales.推动临床审计数据透明化。 2011年7月7日，英国首相在致内阁大臣的透明化与开放数据信函中，承诺将公开国家临床审计与患者结局项目（National Clinical Audit and Patient Outcomes Programme）下属国家级审计项目产出的临床审计数据。 国家食管胃恶性肿瘤审计（National Oesophago-Gastric Cancer Audit）聚焦食管胃（Oesophago-Gastric, OG）癌患者的照护质量。该审计针对所有食管胃恶性肿瘤患者（含根治性治疗与姑息治疗患者）的照护流程与治疗结局开展评估。自2012年4月起，审计范围扩展至食管高级别上皮内瘤变（Oesophageal High-Grade Dysplasia, HGD）患者。 本国家食管胃恶性肿瘤审计是一项高规格的跨机构国家级临床审计项目，由英国卫生与社会保健信息中心、大不列颠及爱尔兰上消化道外科医师协会（Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland, AUGIS）、英国胃肠病学会（British Society of Gastroenterologists, BSG）以及英格兰皇家外科医学院临床疗效单元联合运营。 本审计旨在提升食管胃恶性肿瘤患者的照护质量与生存率，符合《国民保健制度癌症规划》（NHS Cancer Plan）以及英国国家卫生与临床优化研究所（National Institute for Health and Care Excellence, NICE）指南的相关要求。 数据获取 相关数据将在data.gov网站发布。国家食管胃恶性肿瘤审计的年度数据将以CSV格式对外提供。国民保健信托机构（Trusts）与医疗网络将通过机构名称与组织编码进行标识。 数据涵盖内容 本数据用于评估提交至国家食管胃恶性肿瘤审计的各类数据的完整度，同时针对关键绩效指标，统计各信托机构在审计中的参与度与绩效表现。相关细节可查阅《2015年国家食管胃恶性肿瘤审计报告》的附件内容。 - 国民保健信托机构的审计参与情况，以及核心字段的数据完整度 - 患者照护流程相关指标 - 患者照护结局与治疗相关信息 本数据集不包含任何个体患者的明细信息，也不存在可识别患者身份的数据内容。 是否所有信托机构均被纳入？ 英格兰与威尔士境内所有收治食管胃恶性肿瘤确诊患者的国民保健信托机构均被纳入本数据集。 数据覆盖的时间范围 2015年国家食管胃恶性肿瘤审计数据集的覆盖时段为2012年4月1日至2014年3月31日，涵盖英格兰与威尔士境内的所有医院院区。